Full-Dose Heparin May Aid Moderately Ill COVID-19 Patients
Interim results show improvement in primary end point of need for ventilation, other organ-supportive interventions
Vitamin D Deficiency Associated With Increased COVID-19 Risk
Significant association persists after adjustment for race, periodontal disease status, diabetes, and obesity
Children Less Susceptible to SARS-CoV-2 but More Infectious
Asymptomatic individuals less likely to infect others; symptomatic cases more likely to infect others before symptom onset
Bamlanivimab + Etesevimab Reduces SARS-CoV-2 Viral Load
No significant reduction seen in viral load at day 11 with bamlanivimab monotherapy in mild-to-moderate COVID-19
Physician’s Briefing Weekly Coronavirus Roundup
FDA Approves First Monthly Injectable Regimen for HIV
Trials show virologic suppression in comparable numbers of patients receiving monthly injection with Cabenuva, daily current antiretroviral regimen
Antibody Drug May Protect Nursing Home Residents, Staff From COVID-19
Preliminary results of the study conducted by drug maker Eli Lilly have not been peer-reviewed or published
Tocilizumab Does Not Improve Outcomes in Severe COVID-19
Tocilizumab plus standard care no better for improving clinical outcomes at 15 days and may increase mortality
Mortality Decreased for COVID-19 ICU Patients Over Time
Mortality decreased from 43.5 to 19.2 percent between first and last 15-day periods; no change seen in other patient factors
President Biden Unveils Details of National Pandemic Response Plan
On Wednesday, Biden signed three executive orders relating to the coronavirus pandemic shortly after taking office
